Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Hypertension. 2009 May 4;53(6):973–978. doi: 10.1161/HYPERTENSIONAHA.108.121483

Figure 1.

Figure 1

Percent change of forearm vascular conductance (FVC) from baseline after administration of epoprostenol (PGI2) in young compared to older subjects (n=10/group). Values are mean ± SEM.